Capecitabine Orion 150 mg kalvopäällysteiset tabletit

DRUG2 trials

Sponsors

HUS-Yhtymae

Conditions

Breast cancerColon cancerRectal cancer

Phase 3

DPDIMP#1-trial: Impact of DPYD gene test on the safety and efficacy of fluoropyrimidine therapy

CompletedCTIS2024-518448-20-00

HUS-YhtymaeBreast cancer, Colon cancer

Start: 2019-10-17End: 2025-03-17Target: 1000Updated: 2024-10-29

Phase 4

Systemic Neoadjuvant and adjuvant Control by Precision medicine in rectal cancer (SYNCOPE) – approach on high-risk group to reduce metastases

Not yet recruitingCTIS2024-517149-15-00

HUS-YhtymaeRectal cancer

Target: 100Updated: 2024-09-24